Hypothesis testing for the validation of the kinetic spectrophotometric methods for the determination of lansoprazole in bulk and drug formulations via Fe(iii) and Zn(ii) chelates

Drug Testing and Analysis

Volumn 2, Issue 3, 2010, Pages 137-143

  Rahman, Nafisur ^a   Kashif, Mohammad ^b  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b Jubilant Organosys Ltd   (India)

Author keywords

Drug formulations; Interval hypothesis; Kinetic determination; Lansoprazole; Metal chelate; Point hypothesis; Spectrophotometry

Indexed keywords

ABSORBANCE; CHELATION; IRON COMPOUNDS; KINETICS; SPECTROPHOTOMETERS; ZINC COMPOUNDS;

DRUG FORMULATIONS; FIXED TIME METHOD; HYPOTHESIS TESTS; INITIAL RATE METHOD; INTERVAL HYPOTHESIS; KINETIC DETERMINATION; KINETIC SPECTROPHOTOMETRIC METHODS; LANSOPRAZOLE; METAL CHELATE; POINT HYPOTHESIS;

SPECTROPHOTOMETRY;

FERRIC ION; LANSOPRAZOLE; ZINC ION;

ACCURACY; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TEMPERATURE MEASUREMENT;

EID: 77953413469     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.111     Document Type: Article

References (24)

1. H. D. Langtry, M. I. Wild, Drugs 1997, 54, 473.
2. M. F. Zaater, N. Najib, E. Ghanem, Saudi Pharm. J. 1999, 7, 123.
3. A. Avgerinos, T. Karidas, C. Potsides, S. Axarlis, Eur. J. Drug Metab. Pharmacokinet. 1998, 23, 329.
4. K. Borner, E. Borner, H. Lode, Chromatographia 1997, 45, 450.
5. B. Lin, Guangdong Yaoxueyuan Xuebao 1998, 14, 247.
6. D. K. Singh, R. A. Singh, East. Pharm. 1999, 42, 113.
7. K. K. Panday, V. D. Modi, M. C. Satiya, I. A. Modi, B. K. Chakravarthy, T. P. Gandhi, J. Chromatogr. Biomed. Sci. Appl. 1997, 639, 199.
8. D. A. Dogrukol, M. Tuncel, H. Y. Aboul-Enein, Chromatographia 2001, 54, 527.
9. C. Yardimci, N. Ozaltin, Analyst 2001, 126, 361.
10. J. M. A. Zehouri, S. H. A. Madi, Saudi Pharm. J. 2001, 9, 99.
11. A. A. M. Moustafa, J. Pharm. Biomed. Anal. 2000, 22, 45.
12. A. A. M. Wahbi, O. A. Razak, A. A. Gazy, H. Mahgoub, M. S. Moneeb, J. Pharm. Biomed. Anal. 2002, 30, 1133.
13. M. Rajshree, S. Krutika, S. K. Banerjee, Indian J. Pharm. Sci. 1997, 59, 203.
14. S.N.Meyyanathan, R. J. R. Arvinda, B. Suresh, Indian Drugs 1997, 34, 403.
15. A. Puratchikodi, G. Krishnamoorthy, B. Jaykar, R. Valaramathy, East. Pharm. 1999, 42, 127.
16. R. J. Sadana, G. P. Kalpana, East. Pharm. 2000, 43, 101.
17. R. Mashru, S. K. Banerjee, East. Pharm. 1999, 42, 125.
18. F. J. Welcher, The Analytical Uses of Ethylenediaminetetra Acetic Acid, D. van Nostrand Company Inc.: Princeton, New Jersey, 1957.
19. W. C. Vosburg, G. R. Cooper, J. Am. Chem. Soc. 1941, 63, 437.
20. J. Roso, Advanced Physicochemical Experiments. Sir Issac Pitman and Sons: London, 1964.
21. F. Salama, N. El-Abasawy, S. A. Abdel Razeq, M. M. F. Ismail, M. M. Fouad, J. Pharm. Biomed. Anal. 2003, 33, 411.
22. J. N. Miller, Analyst 1991, 116, 3.
23. B. Morelli, Analyst 1983, 108, 870.
24. C. Hartmann, J. S. Verbeke, W. Penninckx, Y. V. Heyden, P. Vankeerberghen, D. L. Massart, Anal. Chem. 1995, 67, 4491